Watch Ruth Faden, director of the Johns Hopkins Berman Institute of Bioethics, discuss the Institute of Medicine report she co-chaired on the need to study the safety of drugs after approval and throughout their time on the market.

BioCentury 06.10.12 - [3] Untying the Knot

Be the first to like.


Leave a Reply